Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Morgan StanleyXSWX:MS -1.20%75 3-Year EPS without NRI Growth Rate is 17.40% as of Mar. 2026, which is 67% above its 10-year median of 10.40. GuruFocus rates XSWX:MS with a GF Score™ of 75/100 and a GF Value™ of CHF128.34. The stock has 8 warning signs investors should review. Among 581 Capital Markets companies, Morgan Stanley ranks better than 53.36% on this metric.
During the past 12 months, Morgan Stanley's average EPS without NRI Growth Rate was 30.30% per year.
During the past 3 years, the average EPS without NRI Growth Rate was 17.40% per year.
During the past 5 years, the average EPS without NRI Growth Rate was 5.70% per year.
During the past 10 years, the average EPS without NRI Growth Rate was 12.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Morgan Stanley was 426.00% per year. The lowest was -26.20% per year. And the median was 10.40% per year.
Morgan Stanley (XSWX:MS) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Morgan Stanley 3-Year EPS without NRI Growth Rate Related Terms
XSWX:MS vs GS, SCHW, HOOD: 3-Year EPS without NRI Growth Rate Comparison
For the Capital Markets subindustry, Morgan Stanley's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Morgan Stanley 3-Year EPS without NRI Growth Rate vs Capital Markets Industry
For the Capital Markets industry and Financial Services sector, Morgan Stanley's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Morgan Stanley's 3-Year EPS without NRI Growth Rate falls into.
Morgan Stanley 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 17.40% mean?
Morgan Stanley (XSWX:MS) has a 3-Year EPS without NRI Growth Rate of 17.40% as of Mar. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Morgan Stanley and its competitors. This is 67% above median its historical median of 10.40. According to the industry distribution chart, Morgan Stanley ranks #271 out of 581 companies in the Capital Markets industry, placing it in the top 46.6%.
Is Morgan Stanley's 3-Year EPS without NRI Growth Rate too high?
Morgan Stanley's current 3-Year EPS without NRI Growth Rate of 17.40% is 67% above median its 10-year median of 10.40. The Capital Markets industry median 3-Year EPS without NRI Growth Rate is 14.80. Morgan Stanley's value of 17.40% is 17.6% above this industry median. Based on the distribution chart, Morgan Stanley ranks #271 out of 581 companies in the Capital Markets industry, which is above the industry midpoint. Overall, Morgan Stanley has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Morgan Stanley's 3-Year EPS without NRI Growth Rate compare to GS and SCHW?
According to the Capital Markets industry distribution chart, Morgan Stanley ranks #271 out of 581 companies for 3-Year EPS without NRI Growth Rate. This puts Morgan Stanley in the upper half of its industry. The industry median 3-Year EPS without NRI Growth Rate is 14.80. Morgan Stanley's value of 17.40% is 17.6% above this benchmark. While the company's 10-year median is 10.40 vs. the industry median of 14.80, Morgan Stanley has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Capital Markets company?
The median 3-Year EPS without NRI Growth Rate among Capital Markets companies is 14.80, based on 581 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Morgan Stanley's current 3-Year EPS without NRI Growth Rate of 17.40% is 17.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Morgan Stanley and its competitors. For the Capital Markets industry, the median 3-Year EPS without NRI Growth Rate is 14.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Morgan Stanley's current 3-Year EPS without NRI Growth Rate is 17.40%, which is 67% above median its own 10-year median of 10.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Morgan Stanley stock overvalued right now?
Morgan Stanley (XSWX:MS) has a current 3-Year EPS without NRI Growth Rate of 17.40%. The stock's GF Value™ is CHF128.34, compared to a current price of CHF173.18 — trading 34.9% above its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 17.40%, which is 67% above median its 10-year median of 10.40 and 17.6% above the Capital Markets industry median of 14.80. Morgan Stanley's overall GF Score™ is 75/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For Morgan Stanley (XSWX:MS), the current 3-Year EPS without NRI Growth Rate is 17.40% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Morgan Stanley (XSWX:MS) Overvalued in 2026?
Based on GuruFocus' analysis, Morgan Stanley stock appears to be overvalued.
The current stock price of CHF173.18 is trading 34.9% above its estimated GF Value™ of CHF128.34.
Key valuation signals for XSWX:MS:
3-Year EPS without NRI Growth Rate: 17.40% (67% above median its 10-year median of 10.40)
GF Value™: CHF128.34 vs. price of CHF173.18 (34.9% above fair value)
Industry Position: 17.6% above the Capital Markets median (#271 of 581)
No single metric tells the full story. See the XSWX:MS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Morgan Stanley is a massive global financial services firm, with offices in 42 countries and more than 82,000 employees as of year-end 2025. The firm cut its teeth in investment banking and institutional trading, where it maintains a strong presence today, but generates the lion share of its income from wealth and asset management franchises, where it boasted $9.3 trillion in client assets at the end of 2025. After reincorporation as a bank holding company in the wake of the global financial crisis, Morgan Stanley also boasts a top 10 banking franchise by deposits, with more than $400 billion in customer deposits, predominately attributable to cash sweeps from its wealth management and brokerage businesses.
75GF Score
Get the complete analysis for XSWX:MS
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:MS has been successfully added to your 
